Home › Funds › Center for Financial Planning, Inc. › ABT

Center for Financial Planning, Inc. position in ABT

ABBOTT LABORATORIES · Health Care

Center for Financial Planning, Inc. reported holding 20,440 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 0.19% of its reported portfolio and ranking #43 among its reported holdings. Center for Financial Planning, Inc. has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)20.44K sh
Reported value held$2.02M
Portfolio Weight0.19%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Center for Financial Planning, Inc.'s ABT position evolved

Center for Financial Planning, Inc. first disclosed a stake in ABT in Q3 2023 at 17,844 shares (US$1.7M). The position peaked in Q3 2025 at 17,660 shares, worth US$2.4M. Across 13 filings, Center for Financial Planning, Inc. increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 20,440 shares valued at US$2.0M — an increase of 120 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 17.84K $1.73M New
Q4 2023 17.84K $1.96M Hold
Q1 2024 17.84K $2.03M Hold
Q2 2024 17.84K $1.85M Hold
Q3 2024 17.01K $1.94M Reduce
Q4 2024 17.01K $1.92M Hold
Q1 2025 17.01K $2.26M Hold
Q2 2025 17.01K $2.31M Hold
Q3 2025 17.66K $2.37M Add
Q4 2025 17.66K $2.21M Hold
Q1 2026 17.66K $1.81M Hold
Q2 2026 20.32K $1.84M Add
Q3 2026 20.44K $2.02M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Center for Financial Planning, Inc. held ABT?

Center for Financial Planning, Inc. has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Center for Financial Planning, Inc.'s current position in ABT?

As of Q3 2026, Center for Financial Planning, Inc. holds 20.44K shares of ABT (ABBOTT LABORATORIES), valued at $2.02M, representing 0.19% of its reported portfolio and ranking #43.

Has Center for Financial Planning, Inc. been buying or selling ABT?

In the latest 13F filing (Q3 2026), Center for Financial Planning, Inc. increased its position in ABT. The position peaked in Q3 2025 at 17.66K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.